GNF-5837 is a potent, selective, and orally bioavailable pan-TRK inhibitor that inhibited tumor growth in a mouse xenograft model derived from RIE cells expressing both TRKA and NGF. The properties of GNF-5837 make it a good tool for the elucidation of TRK biology in cancer and other nononcology indications.
Trk receptor Inhibitors Related Products:
SP600125; Danusertib; GW441756; Altiratinib; Ropotrectinib; Larotrectinib sulfate; Entrectinib; ANA-12